tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SPRY Stock Latest News

ARS Pharmaceuticals: Strategic Growth and Market Penetration Justify Buy Rating
RatingsARS Pharmaceuticals: Strategic Growth and Market Penetration Justify Buy Rating
4d ago
SPRY
ARS Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
ARS Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
7d ago
SPRY
ARS Pharmaceuticals Reports Strong 2024 Financial Results
PremiumCompany Announcements
ARS Pharmaceuticals Reports Strong 2024 Financial Results
8d ago
SPRY
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
PremiumThe Fly
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
9d ago
YY
ACN
ARS Pharmaceuticals: Strong Market Performance and Strategic Advancements Drive Buy Rating
PremiumRatings
ARS Pharmaceuticals: Strong Market Performance and Strategic Advancements Drive Buy Rating
9d ago
SPRY
ARS Pharmaceuticals expects cash to fund operations for at least next 3 years
PremiumThe FlyARS Pharmaceuticals expects cash to fund operations for at least next 3 years
9d ago
SPRY
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
Premium
The Fly
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
9d ago
SPRY
SPRY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SPRY Upcoming Earnings Report: What to Expect?
11d ago
SPRY
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
PremiumThe Fly
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
22d ago
W
AL
ARS Pharmaceuticals initiated with an Outperform at Scotiabank
PremiumThe Fly
ARS Pharmaceuticals initiated with an Outperform at Scotiabank
22d ago
SPRY
ARS Pharmaceuticals: Strategic Developments and Market Opportunities Drive Buy Rating for Neffy
PremiumRatings
ARS Pharmaceuticals: Strategic Developments and Market Opportunities Drive Buy Rating for Neffy
22d ago
SPRY
Closing Bell Movers: MongoDB, Marvell Technology down double digits
PremiumThe Fly
Closing Bell Movers: MongoDB, Marvell Technology down double digits
23d ago
ZS
CXW
ARS Pharmaceuticals announces FDA approval for neffy 1 mg
PremiumThe FlyARS Pharmaceuticals announces FDA approval for neffy 1 mg
24d ago
SPRY
ARS Pharmaceuticals Secures Major Formulary Wins, Strengthens Market Position for neffy
Premium
Ratings
ARS Pharmaceuticals Secures Major Formulary Wins, Strengthens Market Position for neffy
1M ago
SPRY
Closing Bell Movers: Booking gains 3%, Akamai down 8% on earnings
Premium
The Fly
Closing Bell Movers: Booking gains 3%, Akamai down 8% on earnings
1M ago
NU
AMN
ARS Pharmaceuticals says OptumRx, Cigna, Navitus add neffy to formularies
PremiumThe Fly
ARS Pharmaceuticals says OptumRx, Cigna, Navitus add neffy to formularies
1M ago
SPRY
Amazon downgraded, Shopify upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Amazon downgraded, Shopify upgraded: Wall Street’s top analyst calls
2M ago
JCI
OKE
ARS Pharmaceuticals initiated with an Outperform at Oppenheimer
PremiumThe Fly
ARS Pharmaceuticals initiated with an Outperform at Oppenheimer
2M ago
SPRY
ARS Pharmaceuticals files automatic mixed securities shelf
PremiumThe Fly
ARS Pharmaceuticals files automatic mixed securities shelf
2M ago
SPRY
ARS Pharmaceuticals launches neffyinSchools program
PremiumThe FlyARS Pharmaceuticals launches neffyinSchools program
2M ago
SPRY
ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
Premium
The Fly
ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
2M ago
SPRY
ARS Pharmaceuticals Highlights Success and Plans for 2025
Premium
Company Announcements
ARS Pharmaceuticals Highlights Success and Plans for 2025
2M ago
8K
SPRY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >